Arti Vashist's research focuses on the use of nanotechnology in drug delivery systems. Vashist recently received a Young Investigator Pilot Award from the National Cancer Institute’s AIDS and Cancer Specimen Resource to continue her work on developing a nanogel-based anti-HIV drug regimen. She is also pursuing nanotechnology-based therapeutics for ovarian cancer.
Research Interests
- The synthesis, characterization, and biological application of nanoparticles and micro/ nano gels as site-specific drug delivery systems.
- Utilizing nanogels for delivering anti-viral drugs across physiological barriers and also utilizing them as prophylactics for infectious diseases.
Current Grants
- 11094 Arti Vashist (PI) FIU Foundation 03/01/2020-01/8/2022
Nanotechnology-based eradication of Ovarian Cancer: The proposed research will aim to develop biocompatible multi-functional nanotechnology-based systems for ovarian cancer theranostics - R01DA052271 Madhavan Nair M (PI) NIDA 07/01/2020-05/31/2025
Targeting Inflammasome with stable endocannabinoid ligand AMG315: CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid: This proposed research will elucidate the use of CRISPR technology targeting HIV-1 Tat and AMG315 (a novel stable endocannabinoid ligand) in inhibiting HIV infection and associated inflammasome-mediated neuroinflammation in HIV-infected cannabinoid abusers.
Education
- Ph.D., Chemistry, Jamia Millia Islamia & All India Institute of Medical Sciences, New Delhi, India
- MSc Chemistry, Jamia Millia Islamia, New Delhi, India
- BSc (Phys, Chem, Math), Delhi University, New Delhi, India